According to a new report from Intel Market Research, the global Iguratimod market was valued at USD 120 million in 2024 and is projected to reach USD 220 million by 2034, growing at a steady CAGR of 6.8% during the forecast period (2026-2034). This expansion reflects the drug's growing acceptance as a novel therapeutic option for autoimmune conditions, particularly rheumatoid arthritis, across...
Italiano 
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Russian
Romaian
Portuguese (Brazil)
Greek